These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 26980709

  • 1. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X, Liu Y, Lv J, Ding H, Zhang XA, Shao L, Yang N, Cheng H, Sun L, Zhu D, Yang Y, Li A, Han X, Sun Y.
    Oncotarget; 2016 Apr 12; 7(15):20966-80. PubMed ID: 26980709
    [Abstract] [Full Text] [Related]

  • 2. ERα positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells.
    Shi JF, Li XJ, Si XX, Li AD, Ding HJ, Han X, Sun YJ.
    Biochem Biophys Res Commun; 2012 Oct 12; 427(1):47-53. PubMed ID: 22975348
    [Abstract] [Full Text] [Related]

  • 3. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
    Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu C, Qi H, Zhong C, Wang X, Li Z.
    PLoS One; 2012 Oct 12; 7(4):e35957. PubMed ID: 22558281
    [Abstract] [Full Text] [Related]

  • 4. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Jahangiri R, Jamialahmadi K, Gharib M, Emami Razavi A, Mosaffa F.
    Gene; 2019 Feb 15; 685():24-31. PubMed ID: 30359738
    [Abstract] [Full Text] [Related]

  • 5. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
    Roll JD, Rivenbark AG, Sandhu R, Parker JS, Jones WD, Carey LA, Livasy CA, Coleman WB.
    Exp Mol Pathol; 2013 Dec 15; 95(3):276-87. PubMed ID: 24045095
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J, Sui M, Fan W.
    Breast Cancer Res Treat; 2012 Aug 15; 134(3):969-80. PubMed ID: 22374518
    [Abstract] [Full Text] [Related]

  • 7. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
    Yu Z, Xiao Q, Zhao L, Ren J, Bai X, Sun M, Wu H, Liu X, Song Z, Yan Y, Mi X, Wang E, Jin F, Wei M.
    Mol Carcinog; 2015 Sep 15; 54(9):707-19. PubMed ID: 24464625
    [Abstract] [Full Text] [Related]

  • 8. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
    Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang E, Shao L, Li A, Yang N, Han X, Pan B, Zhang Z, Sun L, Sun Y.
    Oncotarget; 2016 Dec 06; 7(49):81452-81462. PubMed ID: 27845892
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.
    Selmin OI, Donovan MG, Skovan B, Paine-Murieta GD, Romagnolo DF.
    Int J Oncol; 2019 Mar 06; 54(3):869-878. PubMed ID: 30664189
    [Abstract] [Full Text] [Related]

  • 11. Liuwei Dihuang prevents postmenopausal atherosclerosis and endothelial cell apoptosis via inhibiting DNMT1-medicated ERα methylation.
    Chen Q, Zhang Y, Meng Q, Wang S, Yu X, Cai D, Cheng P, Li Y, Bian H.
    J Ethnopharmacol; 2020 Apr 24; 252():112531. PubMed ID: 31926314
    [Abstract] [Full Text] [Related]

  • 12. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
    Wang B, Li D, Rodriguez-Juarez R, Farfus A, Storozynsky Q, Malach M, Carpenter E, Filkowski J, Lykkesfeldt AE, Kovalchuk O.
    BMC Cancer; 2018 Aug 13; 18(1):817. PubMed ID: 30103729
    [Abstract] [Full Text] [Related]

  • 13. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
    John Mary DJS, Sikarwar G, Kumar A, Limaye AM.
    Mol Cell Endocrinol; 2020 Mar 15; 504():110701. PubMed ID: 31926189
    [Abstract] [Full Text] [Related]

  • 14. Cucurbitacin B Induces Hypermethylation of Oncogenes in Breast Cancer Cells.
    Dittharot K, Dakeng S, Suebsakwong P, Suksamrarn A, Patmasiriwat P, Promkan M.
    Planta Med; 2019 Mar 15; 85(5):370-378. PubMed ID: 30463098
    [Abstract] [Full Text] [Related]

  • 15. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
    Jahangiri R, Mosaffa F, Emami Razavi A, Teimoori-Toolabi L, Jamialahmadi K.
    J Cell Physiol; 2018 Sep 15; 233(9):7305-7319. PubMed ID: 29574992
    [Abstract] [Full Text] [Related]

  • 16. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.
    Mol Cancer Res; 2008 Aug 15; 6(8):1347-55. PubMed ID: 18708366
    [Abstract] [Full Text] [Related]

  • 17. Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.
    Thewes V, Simon R, Schroeter P, Schlotter M, Anzeneder T, Büttner R, Benes V, Sauter G, Burwinkel B, Nicholson RI, Sinn HP, Schneeweiss A, Deuschle U, Zapatka M, Heck S, Lichter P.
    Cancer Res; 2015 Feb 15; 75(4):720-31. PubMed ID: 25643697
    [Abstract] [Full Text] [Related]

  • 18. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
    Tsuboi K, Kaneko Y, Nagatomo T, Fujii R, Hanamura T, Gohno T, Yamaguchi Y, Niwa T, Hayashi SI.
    J Steroid Biochem Mol Biol; 2017 Mar 15; 167():115-125. PubMed ID: 27888136
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.